Apoptotic interactions of cytochrome c: Redox flirting with anionic phospholipids within and outside of mitochondria

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1757, Issue 5-6, 2006, Pages 648-659

  Bayir, H ^a,b,c   Fadeel, B ^e   Palladino, M J ^c,d   Witasp, E ^e   Kurnikov, I V ^a,c   Tyurina, Y Y ^a,c   Tyurin, V A ^a,c   Amoscato, A A ^c   Jiang, J ^a,c   Kochanek, P M ^b,c   DeKosky, S T ^c   Greenberger, J S ^d   Shvedova, A A ^f   Kagan, V E ^a,c  

^a Center for Free Radical and Antioxidant Health   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Department of Critical Care Medicine ^*  (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Cytochrome c; Mitochondrion; Phospholipid

Indexed keywords

ANTIBODY; CARDIOLIPIN; CYTOCHROME C; OXYGENASE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE;

AMINO ACID SEQUENCE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROGENESIS; CATALYST; CENTRAL NERVOUS SYSTEM DISEASE; COMPLEX FORMATION; CYTOSOL; ELECTRON TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME RELEASE; HUMAN; INFLAMMATION; LIPID OXIDATION; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; ATHEROSCLEROSIS; CARDIOLIPINS; CELL MEMBRANE; CYTOCHROMES C; ELECTRON TRANSPORT; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; OXYGENASES; PEROXIDASES; PHOSPHOLIPIDS; REACTIVE OXYGEN SPECIES;

EID: 33745727023     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2006.03.002     Document Type: Review

References (148)

1. Hackenbrock C.R., Chazotte B., and Gupte S.S. The random collision model and critical-assessment of diffusion and collision in mitochondrial electron-transport. J. Bioenerg. Biomembr. 18 (1986) 331-368
2. Pereverzev M.O., Vygodina T.V., Konstantinov A.A., and Skulachev V.P. Cytochrome c, an ideal antioxidant. Biochem. Soc. Trans. 31 (2003) 1312-1315
3. Stellwagen E. Carboxymethylation of horse heart ferricytochrome c and cyanferricytochrome c. Biochemistry 7 (1968) 2496-2501
4. Theorell H., and Akesson A. Studies on Cytochrome c: II. The optical properties of pure cytochrome c and some of its derivatives. J. Am. Chem. Soc. 3 (1941) 1812-1818
5. Radi R., Turrens J.F., and Freeman B.A. Cytochrome c-catalyzed membrane lipid peroxidation by hydrogen peroxide. Arch. Biochem. Biophys. 288 (1991) 118-125
6. Nantes I., Zucchi M., Nascimento O., and Faljoni-Alario A. Effect of heme iron valence state on the conformation of cytochrome c and its association with membrane interfaces. A CD and EPR investigation. J. Biol. Chem. 276 (2001) 153-158
7. Zucchi M.R., Naschimento O.R., Faljoni-Alario A., Prieto T., and Nantes I.L. Modulation of cytochrome c spin stated by lipid acyl chains: a continuous-wave electron paramagnetic resonance (CW-EPR) study of haem iron. Biochem. J. 370 (2003) 671-678
8. Cassina A.M., Hodara R., Souza J.M., Thomson L., Castro L., Ischiropoulos H., Freeman B.A., and Radi R. Cytochrome c nitration by peroxynitrite. J. Biol. Chem. 275 (2000) 21409-21415
9. Chen Y.R., Deterding L.J., Sturgeon B.E., Tomer K.B., and Mason R.P. Protein oxidation of cytochrome C by reactive halogen species enhances its peroxidase activity. J. Biol. Chem. 277 (2002) 29781-29791
10. Prasad S., Maiti N.C., Mazumdar S., and Mitra S. Reaction of hydrogen peroxide and peroxidase activity in carboxymethylated cytochrome c: spectroscopic and kinetic studies. Biochim. Biophys. Acta 1596 (2002) 63-75
11. Oellerich S., Wackerbarth H., and Hildebrandt P. Conformational equilibria and dynamics of cytochrome c induced by binding of sodium dodecyl sulfate monomers and micelles. Eur. Biophys. J. 32 (2003) 599-613
12. Iwase H., Takatori T., Nagao M., Iwadate K., and Nakajima M. Monoepoxide production from linoleic acid by cytochrome c in the presence of cardiolipin. Biochem. Biophys. Res. Commun. 222 (1996) 83-89
13. Zhang M., Mileykovskaya E., and Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J. Biol. Chem. 280 (2005) 29403-29408
14. Robinson N.C., Zborowski J., and Talbert L.H. Cardiolipin-depleted bovine heart cytochrome c oxidase: binding stoichiometry and affinity for cardiolipin derivatives. Biochemistry 29 (1990) 8962-8969
15. Hayer-Hartl M., Schagger H., von Jagow G., and Beyer K. Interactions of phospholipids with the mitochondrial cytochrome-c reductase studied by spin-label ESR and NMR spectroscopy. Eur. J. Biochem. 209 (1992) 423-430
16. Schagger H. Respiratory chain supercomplexes of mitochondria and bacteria. Biochim. Biophys. Acta 1555 (2002) 154-159
17. Kagan V.E., Tyurin V.A., Jiang J., Tyurina Y.Y., Ritov V.B., Amoscato A.A., Osipov A.N., Belikova N.A., Kapralov A.A., Kini V., Vlasova I.I., Zhao Q., Zou M., Di P., Svistunenko D.A., Kurnikov I.V., and Borisenko G.G. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1 (2005) 223-232
18. Dickerson R.E. The structures of cytochrome c and the rates of molecular evolution. J. Mol. Evol. 1 (1971) 26-45
19. Garcia Fernandez M., Troiano L., Moretti L., Nasi M., Pinti M., Salvioli S., Dobrucki J., and Cossarizza A. Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ. 13 (2002) 449-455
20. Cossarizza A., Pint I.M., Moretti L., Bricalli D., Bianchi R., Troiano L., Fernandez M.G., Balli F., Brambilla P., Mussini C., and Vigano A. Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. J. Infect. Dis. 185 (2002) 299-305
21. Ardail D., Privat J.P., Egret-Charlier M., Levrat C., Lerme F., and Louisot P. Mitochondrial contact sites. Lipid composition and dynamics. J. Biol. Chem. 265 (1990) 18797-18802
22. Lutter M., Perkins G.A., and Wang X. The pro-apoptotic Bcl-2 family member tBid localizes to mitochondrial contact sites. BMC Cell Biol. 2 (2001) 22
23. Kim T.H., Zhao Y., Ding W.X., Shin J.N., He X., Seo Y.W., Chen J., Rabinowich H., Amoscato A.A., and Yin X.M. Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome c release. Mol. Biol. Cell 15 (2004) 3061-3072
24. Imai H., Koumura T., Nakajima R., Nomura K., and Nakagawa Y. Protection from inactivation of the adenine nucleotide translocator during hypoglycaemia-induced apoptosis by mitochondrial phospholipid hydroperoxide glutathione peroxidase. Biochem. J. 371 (2003) 799-809
25. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., and Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1259-1263
26. Gonzalvez F., Bessoule J.J., Rocchiccioli F., Manon S., and Petit P.X. Role of cardiolipin on tBid and tBid/Bax synergistic effects on yeast mitochondria. Cell Death Differ. 12 (2005) 659-667
27. Gonzalvez F., Pariselli F., Dupaigne P., Budihardjo I., Lutter M., Antonsson B., Diolez P., Manon S., Martinou J.C., Goubern M., Wang X., Bernard S., and Petit P.X. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ. 12 (2005) 266-614
28. Sorice M., Circella A., Cristea I.M., Garofalo T., Di Renzo L., Alessandri C., Valesini G., and Esposti M.D. Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ. 11 (2004) 1133-1145
29. Sandra F., Degli Esposti M., Ndebele K., Gona P., Knight D., Rosenquist M., and Khosravi-Far R. Tumor necrosis factor-related apoptosis-inducing ligand alters mitochondrial membrane lipids. Cancer Res. 65 (2005) 8286-9827
30. Iverson S.L., and Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch. Biochem. Biophys. 423 (2004) 37-46
31. Kagan V.E., Borisenko G.G., Tyurina Y.Y., Tyurin V.A., Jiang J., Potapovich A.I., Kini V., Amoscato A.A., and Fujii Y. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radical Biol. Med. 37 (2004) 1963-1985
32. Hao Z., Duncan G.S., Chang C.-C., Elia A., Fang M., Wakeham A., Okada H., Calzascia T., Jang Y., You-Ten A., Yeh W.-C., Ohashi P., Wang X., and Mak T.W. Specific ablation of the apoptotic functions of cytochrome c reveals a differential requirement for cytochrome c and Apaf-1 in apoptosis. Cell 121 (2005) 579-591
33. Cai J., Nelson K.C., Wu M., Sternberg P.J., and Jones D.P. Oxidative damage and protection of the RPE. Prog. Retin Eye Res. 19 (2000) 205-221
34. Raha S., and Robinson B.H. Mitochondria, oxygen free radicals, and apoptosis. Am. J. Med. Genet. 106 (2001) 62-70
35. Ricci J.E., Waterhouse N., and Green D.R. Mitochondrial functions during cell death, a complex (I-V) dilemma. Cell Death Differ. 10 (2003) 488-492
36. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64 (1995) 97-112
37. Mantymaa P., Siitonen T., Guttorm T., Saily M., Kinnula V., Savolainen E.R., and Koistinen P. Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br. J. Haematol. 108 (2000) 574-581
38. Epperly M.W., Gretton J.E., Sikora C.A., Jefferson M., Bernarding M., Nie S., and Greenberger J.S. Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage. Radiat. Res. 160 (2003) 568-578
39. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., Pelliccia G., Luzi L., Minucci S., Marcaccio M., Pinton P., Rizzuto R., Bernardi P., Paolucci F., and Pelicci P.G. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122 (2005) 221-233
40. Sato K., Nagao T., Kakumoto M., Kimoto M., Otsuki T., Iwasaki T., Tokmakov A.A., Owada K., and Fukami Y. Adaptor protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src. J. Biol. Chem. 277 (2002) 29568-29576
41. Bai J., and Cederbaum A.I. Mitochondrial catalase and oxidative injury. Biol. Signals Recept. 10 (2001) 189-199
42. Miranda-Vizuete A., Damdimopoulos A.E., and Spyrou G. The mitochondrial thioredoxin system. Antioxid. Redox Signal. 2 (2000) 801-810
43. Rhee S.G., Kang S.W., Chang T.S., Jeong W., and Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35-41
44. Flohe L. Glutathione peroxidase. Basic Life Sci. 49 (1988) 663-668
45. Andoh T., Chock P.B., and Chiueh C.C. The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J. Biol. Chem. 277 (2002) 9655-9660
46. Chen Y., Cai J., Murphy T.J., and Jones D.P. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277 (2002) 33242-33248
47. Bai J., Rodriguez A.M., Melendez J.A., and Cederbaum A.I. Overexpression of catalase in cytosolic or mitochondrial compartment protects HepG2 cells against oxidative injury. J. Biol. Chem. 274 (1999) 26124-26217
48. Matsura T., Kai M., Jiang J., Babu H., Kini V., Kusumoto C., Yamada K., and Kagan V.E. Endogenously generated hydrogen peroxide is required for execution of melphalan-induced apoptosis as well as oxidation and externalization of phosphatidylserine. Chem. Res. Toxicol. 17 (2004) 685-696
49. Ran Q., Van Remmen H., Gu M., Qi W., Roberts L.J.N., Prolla T., and Richardson A. Embryonic fibroblasts from Gpx4+/- mice: a novel model for studying the role of membrane peroxidation in biological processes. Free Radic. Biol. Med. 35 (2003) 1101-1109
50. Ran Q., Liang H., Gu M., Qi W., Walter C.A., Roberts L.J.N., Herman B., Richardson A., and Van Remmen H. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J. Biol. Chem. 279 (2004) 55137-55146
51. Enoksson M., Fernandes A.P., Prast S., Lillig C.H., Holmgren A., and Orrenius S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem. Biophys. Res. Commun. 327 (2005) 774-779
52. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 441-446
53. Joza N., Susin S.A., Daugas E., Stanford W.L., Cho S.K., Li C.Y.J., Sasaki T., Elia A.J., Cheng H.-Y.M., Ravagnan L., Ferri K.F., Zamzami N., Wakeham A., Hakem R., Yoshida H., Kong Y.-Y., Mak T.W., Zúñiga-Pflücker J.C., Kroemer G., and Penninger J.M. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410 (2001) 549-554
54. Candé C., Vahsen N., Métivier D., Tourrière H., Chebli K., Garrido C., Tazi J., and Kroemer G. Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J. Cell Sci. 117 (2004) 4461-4468
55. Ghafourifar P., and Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 26 (2005) 190-195
56. Kanai A., Epperly M.W., Pearce L., Birder L., Zeidel M., Meyers S., Greenberger J.S., de Groat W., Apodaca G., and Peterson J. Differing roles of mitochondrial nitric oxide synthase in cardiomyocytes and urothelial cells. Am. J. Physiol., Heart Circ. Physiol. 286 (2004) H13-H21
57. Pearce L.L., Kanai A.J., Epperly M.W., and Peterson J. Nitrosative stress results in irreversible inhibition of purified mitochondrial complexes I and III without modification of cofactors. Nitric Oxide 13 (2005) 254-263
58. MacMillan-Crow L.A., Crow J.P., and Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37 (1998) 1613-1622
59. Chen Y.R., Gunther M.R., and Mason R.P. An electron spin resonance spin-trapping investigation of the free radicals formed by the reaction of mitochondrial cytochrome c oxidase with H2O2. J. Biol. Chem. 274 (1999) 3308-3314
60. Weinberg A., Nylander K.D., Yan C., Ma L., Hsia C.J., Tyurin V.A., Kagan V.E., and Schor N.F. Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA. Brain Res. 1012 (2004) 13-21
61. Liang Q., A.D. S., Pan S., Tyurin V.A., Kagan V.E., Hastings T.G., and Schor N.F. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem. Pharmacol. 70 (2005) 1371-1381
62. Kentner R., Safar P., Behringer W., Wu X., Kagan V.E., Tyurina Y.Y., Henchir J., Ma L., Hsia C.J., and Tisherman S.A. Early antioxidant therapy with Tempol during hemorrhagic shock increases survival in rats. J. Trauma 53 (2002) 968-977
63. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Patel N.S., Caputi A.P., and Thiemermann C. Tempol reduces the activation of nuclear factor-kappaB in acute inflammation. Free Radical Res. 38 (2004) 813-819
64. Sepodes B., Maio R., Pinto R., Marques C., Mendes-do-Vale J., McDonald M.C., Thiemermann C., and Mota-Filipe H. Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant. Proc. 36 (2004) 849-853
65. Patel N.S., Chatterjee P.K., Chatterjee B.E., Cuzzocrea S., Serraino I., Brown P.A., Stewart K.N., Mota-Filipe H., and Thiemermann C. TEMPONE reduces renal dysfunction and injury mediated by oxidative stress of the rat kidney. Free Radical Biol. Med. 33 (2002) 1575-1589
66. Li H., Ma L., Hsia C.J., Zweier J.L., and Kuppusamy P. Polynitroxyl-albumin (PNA) enhances myocardial infarction therapeutic effect of tempol in rat hearts subjected to regional ischemia-reperfusion. Free Radical Biol. Med. 32 (2002) 712-719
67. Wipf P., Xiao J., Jiang J., Belikova N.A., Tyurin V.A., Fink M.P., and Kagan V.E. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J. Am. Chem. Soc. 127 (2005) 12460-12461
68. Dhanasekaran A., Kotamraju S., Karunakaran C., Kalivendi S.V., Thomas S., Joseph J., and Kalyanaraman B. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radical Biol. Med. 39 (2005) 567-583
69. Fleming C., Maldjian A., Da Costa D., Rullay A.K., Haddleton D.M., John J.S., Penny P., Noble R.C., Cameron N.R., and Davis B.G. A carbohydrate-antioxidant hybrid polymer reduces oxidative damage in spermatozoa and enhances fertility. Nat. Chem. Biol. 1 (2005) 270-274
70. Shidoji Y., Hayashi K., Komura S., Ohishi N., and Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem. Biophys. Res. Commun. 264 (1999) 343-347
71. Nakagawa Y. Initiation of apoptotic signal by the peroxidation of cardiolipin of mitochondria. Ann. N. Y. Acad. Sci. 1011 (2004) 177-184
72. Petrosillo G., Ruggiero F.M., and Paradies G. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J. 17 (2003) 2202-2208
73. Petrosillo G., Ruggiero F.M., Pistolese M., and Paradies G. Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin. J. Biol. Chem. 279 (2004) 53103-53108
74. Moreira P.I., Smith M.A., Zhu X., Nunomura A., Castellani R.J., and Perry G. Oxidative stress and neurodegeneration. Ann. N. Y .Acad. Sci. 1043 (2005) 545-552
75. Greco A., and Minghetti L. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases. Curr. Neurovasc. Res. 1 (2004) 341-354
76. Montine T.J., Montine K.S., McMahan W., Markesbery W.R., Quinn J.F., and Morrow J.D. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid. Redox Signal 7 (2005) 269-275
77. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 (2003) S26-S38
78. Lewen A., Matz P., and Chan P.H. Free radical pathways in CNS injury. J. Neurotrauma 17 (2000) 871-890
79. Graham S.H., and Chen J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21 (2001) 99-109
80. Henshall D.C., Chen J., and Simon R.P. Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures. J. Neurochem. 74 (2000) 1215-1223
81. Graham S., Chen J., and Clark R.S. Bcl-2 family gene products in cerebral ischemia and traumatic brain injury. J. Neurotrauma 17 (2000) 831-841
82. Tarkowski E., Rosengren L., Blomstrand C., Jensen C., Ekholm S., and Tarkowski A. Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 30 (1999) 321-327
83. Waters K.A., Meehan B., Huang J.Q., Gravel R.A., Michaud J., and Cote A. Neuronal apoptosis in sudden infant death syndrome. Pediatr. Res. 45 (1999) 166-712
84. Tyurin V.A., Tyurina Y.Y., Borisenko G.G., Sokolova T.V., Ritov V.B., Quinn P.J., Rose M., Kochanek P., Graham S.H., and Kagan V.E. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J. Neurochem. 75 (2000) 2178-2189
85. Bayir H., Kagan V.E., Tyurina Y.Y., Tyurin V.A., Ruppel R.A., Adelson P.D., Graham S.H., Janesko K., Clark R.S., and Kochanek P.M. Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr. Res. 51 (2002) 571-578
86. Yao Y., Zhukareva V., Sung S., Clark C.M., Rokach J., Lee V.M., Trojanowski J.Q., and Pratico D. Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia. Neurology 61 (2003) 475-478
87. Kirkland R.A., Adibhatla R.M., Hatcher J.F., and J.L. F. Loss of cardiolipin and mitochondria during programmed neuronal death: evidence of a role for lipid peroxidation and autophagy. Neuroscience 115 (2002) 587-602
88. Kirkland R.A., and Franklin J.L. Evidence for redox regulation of cytochrome C release during programmed neuronal death: antioxidant effects of protein synthesis and caspase inhibition. J. Neurosci. 21 (2001) 1949-1963
89. Kirkinezos I.G., Bacman S.R., Hernandez D., Oca-Cossio J., Arias L.J., Perez-Pinzon M.A., Bradley W.G., and Moraes C.T. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. 25 (2005) 164-172
90. Gohil V.M., Gvozdenovic-Jeremic J., Schlame M., and Greenberg M.L. Binding of 10-N-nonyl acridine orange to cardiolipin-deficient yeast cells: implications for assay of cardiolipin. Anal. Biochem. 343 (2005) 350-352
91. Mileykovskaya E., Dowhan W., Birke R.L., Zheng D., Lutterodt L., and Haines T.H. Cardiolipin binds nonyl acridine orange by aggregating the dye at exposed hydrophobic domains on bilayer surfaces. FEBS Lett. 507 (2001) 187-190
92. Tyurin V.A., Tyurina Y.Y., Ritov V., Du L., Jiang J., Zou M., Zhang X., Clark R.S.B., Kochanek P.M., Kagan V.E., and Bayir H. Cytochrome c functions as peroxidase catalyzing cardiolipin peroxidation during apoptosis. Soc. Neurosci. Annu. Meet. 12-16 (2005 Nov) (#785.710)
93. Jiang X., and Wang X. Cytochrome c-mediated apoptosis. Annu. Rev. Biochem. 73 (2004) 87-106
94. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
95. Hampton M.B., Zhivotovsky B., Slater A.F., Burgess D.H., and Orrenius S. Importance of the redox state of cytochrome c during caspase activation in cytosolic extracts. Biochem. J. 329 (1998) 95-99
96. Kagan V.E., Fabisiak J.P., Shvedova A.A., Tyurina Y.Y., Tyurin V.A., Schor N.F., and Kawai K. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett. 477 (2000) 1-7
97. Kagan V.E., Borisenko G.G., Serinkan B.F., Tyurina Y.Y., Tyurin V.A., Jiang J., Liu S.X., Shvedova A.A., Fabisiak J.P., Uthaisang W., and Fadeel B. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine. Am. J. Physiol.: Lung Cell. Mol. Physiol. 285 (2003) 1-17
98. Arroyo A., Modriansky M., Serinkan F.B., Bello R.I., Matsura T., Jiang J., Tyurin V.A., Tyurina Y.Y., Fadeel B., and Kagan V.E. NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance. J. Biol. Chem. 277 (2002) 49965-49975
99. Kagan V.E., Gleiss B., Tyurina Y.Y., Tyurin V.A., Elenström-Magnusson C., Liu S.-X., Serinkan F.B., Arroyo A., Chandra J., Orrenius S., and Fadeel B. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J. Immunol. 169 (2002) 487-499
100. Tyurina Y.Y., Serinkan F.B., Tyurin V.A., Kini V., Yalowich J.C., Schroit A.J., Fadeel B., and Kagan V.E. Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization and macrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J. Biol. Chem. 279 (2004) 6056-6064
101. Tyurina Y.Y., Kawai K., Tyurin V.A., Liu S.X., Kagan V.E., and Fabisiak J.P. The plasma membrane is the site of selective phosphatidylserine oxidation during apoptosis: role of cytochrome c. Antioxid. Redox Signal. 6 (2004) 209-225
102. Fabisiak J.P., Kagan V.E., Ritov V.B., Johnson D.E., and Lazo J.S. Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis. Am. J. Physiol.: Cell Physiol. 272 (1997) 675-684
103. Fadok V.A., de Cathelineau A., Daleke D.L., Henson P.M., and Bratton D.L. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 276 (2001) 1071-1077
104. Matsura T., Togawa A., Kai M., Nishida T., Nakada J., Ishibe Y., Kojo S., Yamamoto Y., and Yamada K. The presence of oxidized phosphatidylserine on Fas-mediated apoptotic cell surface. Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids 1736 (2005) 181-188
105. Fadeel B., and Xue D. PS externalization: from corpse clearance to drug delivery. Cell Death Differ. 13 (2006) 360-362
106. Fadeel B. Programmed cell clearance. Cell Mol. Life Sci. 60 (2003) 2575-2585
107. Arur S., Uche U.E., Rezaul K., Fong M., Scranton V., Cowan A.E., Mohler W., and Han D.K. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell. 4 (2003) 587-598
108. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., Bratton D.L., Oldenborg P.A., Michalak M., and Henson P.M. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123 (2005) 321-334
109. Lauber K., Bohn E., Kröber S.M., Xiao Y., Blumenthal S.G., Lindemann R.K., Marini P., Wiedig C., Zobywalski A., Baksh S., Xu Y., Autenrieth I.B., Schulze-Osthoff K., Belka C., Stuhler G., and Wesselborg S. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113 (2003) 717-730
110. Kim S.J., Gershov D., Ma X., Brot N., and Elkon K.B. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J. Exp. Med. 196 (2002) 655-665
111. Panasenko O.M., Spalteholz H., Schiller J., and Arnhold J. Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radical Biol. Med. 34 (2003) 362-553
112. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
113. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6 (2005) 1191-1197
114. Fadeel B., and Kagan V.E. Apoptosis and macrophage clearance of neutrophils: regulation by reactive oxygen species. Redox Rep. 8 (2003) 143-150
115. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., and Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 390 (1997) 350-351
116. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
117. Huynh M.L., Fadok V.A., and Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109 (2002) 41-50
118. Roos D., de Boer M., Kuribayashi F., Meischl C., Weening R.S., Segal A.W., Åhlin A., Nemet K., Hossle J.P., Bernatowska-Matuszkiewicz E., and Middleton-Price H. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87 (1996) 1663-1681
119. Fadeel B., Åhlin A., Henter J.-I., Orrenius S., and Hampton M. Involvement of caspases in neutrophil apoptosis: regulation of reactive oxygen species. Blood 92 (1998) 4808-4818
120. Hampton M.B., Vissers M.C., Keenan J.I., and Winterbourn C.C. Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease. J. Leukocyte Biol. 71 (2002) 775-781
121. Brown J.R., Goldblatt D., Buddle J., Morton L., and Thrasher A.J. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J. Leukocyte Biol. 73 (2003) 591-599
122. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., and Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol., Lung Cell. Mol. Physiol. 289 (2005) L698-L708
123. Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A., and Webb T.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 77 (2004) 117-125
124. Konduru N.V., Tyurina Y.Y., Shvedova A.A., Starr A., Bayir H., and Kagan V.E. Phosphatidylserine functionalization of single walled carbon nanotubes confers a recognition signal for macrophages. 1st International Conference on Nanotoxicology: Biomedical Aspects, Miami, Florida, January 29-February 1 (2006)
125. Serinkan B.F., Gambelli F., Potapovich A.I., Babu H., Di Giuseppe M., Ortiz L.A., Fabisiak J.P., and Kagan V.E. Apoptotic cells quench reactive oxygen and nitrogen species and modulate TNF-alpha/TGF-beta1 balance in activated macrophages: involvement of phosphatidylserine-dependent and -independent pathways. Cell Death Differ. 12 (2005) 1141-1144
126. Kagan V.E., Bayir H., and Shvedova A.A. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine: Nanotechnology, Biology and Medicine 1 (2005) 313-316
127. Price B.E., Rauch J., Shia M.A., Walsh M.T., Lieberthal W., Gilligan H.M., O'Laughlin T., Koh J.S., and Levine J.S. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J. Immunol. 157 (1996) 2201-2208
128. Vay D., Rigamonti C., Vidali M., Mottaran E., Alchera E., Occhino G., Sartori M., and Albano E. Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes. J. Hepatol. 44 (2006) 183-189
129. Hörkkö S., Olee T., Mo L., Branch D.W., Woods Jr. V.L., Palinski W., Chen P.P., and Witztum J.L. Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein. Circulation 103 (2001) 941-946
130. Manfredi A.A., Rovere P., Galati G., Heltai S., Bozzolo E., Soldini L., Davoust J., Balestrieri G., Tincani A., and Sabbadini M.G. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum. 41 (1998) 205-214
131. Binder C.J., Shaw P.X., Chang M.K., Boullier A., Hartvigsen K., Hörkkö S., Miller Y.I., Woelkers D.A., Corr M., and Witztum J.L. The role of natural antibodies in atherogenesis. J. Lipid Res. 46 (2005) 1353-1363
132. Binder C.J., Chang M.K., Shaw P.X., Miller Y.I., Hartvigsen K., Dewan A., and Witztum J.L. Innate and acquired immunity in atherogenesis. Nat. Med. 8 (2002) 1218-1226
133. Binder C.J., and Silverman G.J. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin. Immunopathol. 26 (2005) 385-404
134. Chang M.K., Bergmark C., Laurila A., Hörkkö S., Han K.H., Friedman P., Dennis E.A., and Witztum J.L. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 6353-6358
135. Chang M.K., Binder C.J., Torzewski M., and Witztum J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11308-13043
136. Shaw P.X., Hörkkö S., Chang M.K., Curtiss L.K., Palinski W., Silverman G.J., and Witztum J.L. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105 (2000) 1731-1740
137. Hörkkö S., Bird D.A., Miller E., Itabe H., Leitinger N., Subbanagounder G., Berliner J.A., Friedman P., Dennis E.A., Curtiss L.K., Palinski W., and Witztum J.L. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103 (1999) 117-128
138. Chang M.K., Binder C.J., Miller Y.I., Subbanagounder G., Silverman G.J., Berliner J.A., and Witztum J.L. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200 (2004) 1359-1370
139. Savill J., Dransfield I., Gregory C., and Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev., Immunol. 2 (2002) 795-965
140. Bochkov V.N., Kadl A., Huber J., Gruber F., Binder B.R., and Leitinger N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419 (2002) 77-81
141. Bratton D.L., and Henson P.M. Autoimmunity and apoptosis: refusing to go quietly. Nat. Med. 11 (2005) 26-27
142. Frostegård J., Svenungsson E., Wu R., Gunnarsson I., Lundberg I.E., Klareskog L., Hörkkö S., and Witztum J.L. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 52 (2005) 192-200
143. Kinchen J.M., and Hengartner M.O. Tales of cannibalism, suicide, and murder: programmed cell death in C. elegans. Curr. Top. Dev. Biol. 65 (2005) 1-45
144. Wang X., Yang C., Chai J., Shi Y., and Xue D. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298 (2002) 1587-1592
145. Fadeel B., and Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 258 (2005) 479-517
146. Green D.R., and Kroemer G. Pharmacological manipulation of cell death: clinical applications in sight?. J. Clin. Invest. 115 (2005) 2610-2617
147. Belikova N.A., Vladimirov Y.A., Osipov A.N., Kapralov A.A., Tyurin V.A., Potapovich M.V., Basova L.V., Peterson J., Kurnikov I.V., and Kagan V.E. Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes. Biochemistry 45 (2006) 4998-5009
148. Vlasova I.I., Tyurin V.A., Kapralov A.A., Kurnikov I.V., Osipov A.N., Potapovich M.V., Stoyanovsky D.A., and Kagan V.E. Nitric oxide inhibits peroxidase activity of cytochrome c/cardiolipin complex and blocks cardiolipin oxidation. J. Biol. Chem. (2006) [Epub ahead of print]